Stockscreener 앱 받기
12.49
4.00%
0.48
시간 외 거래:
12.49
전일 마감가:
$12.01
열려 있는:
$11.78
하루 거래량:
2.31M
Relative Volume:
2.76
시가총액:
$961.18M
수익:
-
순이익/손실:
$-209.96M
주가수익비율:
-4.2054
EPS:
-2.97
순현금흐름:
$-176.27M
1주 성능:
-0.48%
1개월 성능:
+11.22%
6개월 성능:
+58.70%
1년 성능:
+67.43%
1일 변동 폭
$11.43
$13.04
1주일 범위
$11.19
$13.04
52주 변동 폭
$4.92
$17.00
레플리뮨 Stock (REPL) Company Profile
명칭
Replimune Group Inc
전화
(781) 222-9600
주소
500 UNICORN PARK, WOBURN, MA
REPL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
12.49 | 961.18M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
레플리뮨 Stock (REPL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2023-04-17 | 재개 | Piper Sandler | Overweight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2020-11-17 | 개시 | BTIG Research | Buy |
| 2020-11-02 | 개시 | Jefferies | Buy |
| 2020-10-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2019-09-04 | 개시 | ROTH Capital | Buy |
| 2019-07-23 | 개시 | Chardan Capital Markets | Buy |
| 2019-07-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-07-08 | 개시 | H.C. Wainwright | Buy |
| 2019-04-25 | 개시 | Wedbush | Outperform |
| 2019-01-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-08-14 | 개시 | JP Morgan | Overweight |
| 2018-08-14 | 개시 | Leerink Partners | Outperform |
모두보기
레플리뮨 주식(REPL)의 최신 뉴스
Replimune Group (NASDAQ:REPL) Stock Price Up 8.2%Here's Why - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 6,759 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Insider Selling: Replimune Group, Inc. (NASDAQ:REPL) CEO Sells 10,000 Shares of Stock - MarketBeat
Replimune CEO Sushil Patel sells $124,200 in company stock - Investing.com
Replimune CEO Sushil Patel sells $124,200 in company stock By Investing.com - Investing.com UK
Wellington Management Group LLP Decreases Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
BNP Paribas Financial Markets Buys 6,748 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Trading Down 4.7%Here's Why - MarketBeat
When (REPL) Moves Investors should Listen - Stock Traders Daily
Replimune's SWOT analysis: biotech's melanoma treatment stock nears key milestones By Investing.com - Investing.com South Africa
Replimune's SWOT analysis: biotech's melanoma treatment stock nears key milestones - Investing.com India
Replimune Group, Inc. (NASDAQ:REPL) Short Interest Down 16.5% in November - MarketBeat
Fmr LLC Sells 120,776 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Fmr LLC Has $6.87 Million Position in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Charles Schwab Investment Management Inc. Buys 52,498 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Charles Schwab Investment Management Inc. Purchases 52,498 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Jacobs Levy Equity Management Inc. Sells 44,153 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
The Manufacturers Life Insurance Company Increases Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Receives $17.29 Average PT from Analysts - MarketBeat
Intech Investment Management LLC Buys New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Where are the Opportunities in (REPL) - Stock Traders Daily
Replimune Group, Inc. (NASDAQ:REPL) Holdings Reduced by Redmile Group LLC - MarketBeat
Parkman Healthcare Partners LLC Buys 238,747 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune stock target raised to $19 on BLA submission By Investing.com - Investing.com Canada
Baker BROS. Advisors LP Has $121.06 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Algert Global LLC - MarketBeat
Braidwell LP Acquires 2,057,460 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune Group Announces Pricing of Public Offering - Defense World
Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch - Seeking Alpha
Replimune Group Amends Sales Agreement with Leerink Partners LLC - Defense World
Replimune reduces offering size in amended sales agreement - Investing.com
Replimune reduces offering size in amended sales agreement By Investing.com - Investing.com Australia
SEC Form 424B5 filed by Replimune Group Inc. - Quantisnow
Cancer firm Replimune readies $125 million offering - The Pharma Letter
REPLReplimune Group, Inc. Latest Stock News & Market Updates - StockTitan
Replimune announces $125 million public offering By Investing.com - Investing.com South Africa
Replimune's SWOT analysis: stock outlook as RP1 nears key milestones By Investing.com - Investing.com Canada
Replimune Announces Pricing of Upsized Public Offering - The Manila Times
Replimune Prices $140M Upsized Public Offering of Common Stock & Warrants | REPL Stock News - StockTitan
Replimune's SWOT analysis: stock outlook as RP1 nears key milestones - Investing.com
How to Take Advantage of moves in (REPL) - Stock Traders Daily
Replimune announces $125 million public offering - Investing.com India
Replimune Announces Proposed Public Offering - The Manila Times
Canadian Dollar/Japanese Yen (CADJPY) QuotePress Release - The Globe and Mail
Replimune Group (NASDAQ:REPL) Price Target Raised to $18.00 - Defense World
Replimune Group (NASDAQ:REPL) Earns Buy Rating from HC Wainwright - Defense World
Replimune's stock surges 19% after-hours on FDA BLA submission - MSN
Replimune Group (NASDAQ:REPL) Reaches New 52-Week High on Analyst Upgrade - MarketBeat
BMO Capital Markets Increases Replimune Group (NASDAQ:REPL) Price Target to $18.00 - MarketBeat
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry? - Simply Wall St
레플리뮨 (REPL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):